関節置換用装置市場 – 2030年までの世界予測

Report Overview

The global joint replacement devices market is expected to reach 31.09 billion by 2030 from USD 23.42 billion in 2024, at a CAGR of 4.8% from 2024 to 2030.

世界の関節置換用装置市場は、2024 年の 234 億 2000 万米ドルから 2030 年までに 310 億 9000 万米ドルに達し、2024 年から 2030 年までの CAGR は 4.8% になると予想されています。

Technological advancements such as use of 3D printing with the manufacturing process, introduction of smart implants, and increased access to latest and innovative implants supports the growth of joint replacement devices market. Further, rising number of sport injuries and increased incidence of accidents that may result in fractures damage to the joints has resulted in rising demand for the joint replacement devices.

製造プロセスでの 3D プリンティングの使用、スマート インプラントの導入、最新かつ革新的なインプラントへのアクセスの増加などの技術の進歩が、関節置換用装置市場の成長を支えています。さらに、スポーツ傷害の増加と関節の骨折損傷を引き起こす可能性のある事故の発生率の増加により、関節置換用装置の需要が高まっています。

“The knee replacement devices segment of product segment held the largest share of the market in 2023”

The joint replacement devices market is segmented based on product into knee replacement devices, hip replacement devices, shoulder replacement devices, elbow replacement devices, ankle replacement devices, wrist replacement devices, other replacement devices, and bone graft substitutes. The knee replacement devices accounted for a the highest share in 2023. Launch of smart knee replacement devices, rise in number of obese population, and increasing awareness initiatives is anticipated to fuel the growth of the segment. Developments knee replacement procedures with an assistance of robotic platform improves patient outcome significtly and is one of the important factors propelling the segment. For instance, the Mako Total Knee Replacement from Stryker Corporation (US) may result in less discomfort and a reduced recovery period as compared to traditional surgery.

“The total replacement segment of surgery type segment held the largest share of the market in 2023”

The joint replacement devices market can be segmented based on surgery type into total replacement, partial replacement, and revision replacement. Growing number for joint replacement surgeries such as knee and hip replacement surgeries and the unique properties of newly launched implants such as longevity and resistance to corrosion drives the segment growth. Increasing funding opportunities and advancements in robotic surgery drives the segment growth. Furthermore, the new and innovative implants assist with reduction in pain, fewer follow ups, reduced revisions, etc. that ultimately supports the growth of the market.

“The ambulatory care centers and trauma units segment for the end user segment is projected to register a significant CAGR during the forecast period.”

The joint replacement devices market is segmented by end-users into hospitals & surgical centers, ambulatory care centers & trauma units, and orthopedic clinics. The ambulatory care centers and trauma units are expected to witness a significant growth during the forecast period. According to Definitive Healthcare there has been a 304% rise in knee replacement surgical procedures performed in ambulatory surgery centers during the period of 2018-2022. Increased accessibility and cost effectiveness at ambulatory care centers anticipated to propel the segment growth. Furthermore, rising preference for minimally invasive surgical techniques is expected to support the growth of this segment.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”

The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in joint replacement devices market. Increasing number of investments, improved healthcare infrastructure and increasing investments in the emerging countries, majorly supports the demand for joint replacement devices. Furthermore, market leaders taking remarkable efforts to strengthen their reach in the Asia Pacific market to meet the growing demand for joint replacement devices. According to International Osteoporosis Foundation, more than 50% of osteoporotic hip fractures are expected to occur by 2050.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and Middle East & Africa – 2%

The prominent players in the joint replacement devices market are as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany), Arthrex, Inc.(US), Enovis (US), Globus Medical, Inc. (US),  Acumed LLC (US), Orthofix Medical Inc.(US) , MicroPort Scientiifc Corporation (China), CONMED Corporation (US), Medacta International (Switzerland), Paragon 28, Inc. (US) and, Meril Life Sciences Pvt. Ltd. (India).

The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments, and key market strategies.

Research  Coverage

This report studies the joint replacement devices market based on product, surgery type, type, technique, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall joint replacement devices market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

• Analysis of key drivers (increasing demand for minimally invasive orthopaedic surgical procedures and rising number of sports injuries, increasing prevalence of orthopaedic diseases and disorders, and increasing research funding and initiatives adopted by orthopaedic manufacturers to promoted brand awareness, increasing adoption of sensor-based implants), restraints (risk and complications associated with orthopaedic surgical procedures, high costs associated with orthopaedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (rising number of hospitals and shift towards outpatient care, advancement in robotic assisted orthopaedic surgeries and 3D printing), and challenges (dearth of skilled orthopaedic surgeons) influencing the growth of the joint replacement devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the joint replacement devices market
• Market Development: Comprehensive information about lucrative markets–the report analyses the joint replacement devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the joint replacement devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).

Table of Contents

1               INTRODUCTION              30

1.1           STUDY OBJECTIVES       30

1.2           MARKET DEFINITION   30

1.3           STUDY SCOPE   31

1.3.1        MARKET SEGMENTATION AND GEOGRAPHICAL SPREAD                31

1.3.2        INCLUSIONS & EXCLUSIONS       32

1.3.3        YEARS CONSIDERED      33

1.4           CURRENCY CONSIDERED            33

1.5           STAKEHOLDERS               33

2               RESEARCH METHODOLOGY       34

2.1           RESEARCH DATA              34

2.1.1        SECONDARY DATA          35

2.1.1.1    Key sources for secondary research   35

2.1.1.2    Key objectives of secondary research                 35

2.1.2        PRIMARY DATA 36

2.1.2.1    Key primary sources             36

2.1.2.2    Key objectives of primary research    36

2.1.2.3    Key primary insights            37

2.1.2.4    Breakdown of primary interviews      37

2.2           MARKET SIZE ESTIMATION         38

2.2.1        BOTTOM-UP APPROACH              39

2.2.1.1    Company revenue estimation approach            40

2.2.1.2    Customer-based market estimation   41

2.2.1.3    Growth forecast approach   42

2.2.1.4    CAGR projections                 42

2.3           DATA TRIANGULATION                43

2.4           MARKET SHARE ANALYSIS           44

2.5           STUDY ASSUMPTIONS  44

2.5.1        PARAMETRIC ASSUMPTIONS     44

2.5.2        GROWTH RATE ASSUMPTIONS 44

2.6           RESEARCH LIMITATIONS             45

2.7           RISK ASSESSMENT           45

3               EXECUTIVE SUMMARY  46

4               PREMIUM INSIGHTS       51

4.1           JOINT REPLACEMENT DEVICES MARKET OVERVIEW                 51

4.2           NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2024 VS. 2030 (USD MILLION)      52

4.3           EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,

2024 VS. 2030 (USD MILLION)      53

4.4           ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2024 VS. 2030 (USD MILLION)      54

4.5           GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET            55

5               MARKET OVERVIEW       56

5.1           INTRODUCTION              56

5.2           MARKET DYNAMICS       56

5.2.1        DRIVERS               57

5.2.1.1    Rising prevalence of orthopedic diseases and disorders 57

5.2.1.2    Increasing demand for minimally invasive surgery         57

5.2.1.3    Rising adoption of sensor-based implants        58

5.2.1.4    Rising number of sports injuries        58

5.2.1.5    Increasing research funding                59

5.2.2        RESTRAINTS      59

5.2.2.1    Risks and complications associated with orthopedic surgical procedures             59

5.2.2.2    Reduced reimbursement rates for orthopedic surgeries 60

5.2.2.3    High cost of orthopedic surgery         60

5.2.3        OPPORTUNITIES              60

5.2.3.1    Advancements in robotic surgery and 3D printing         60

5.2.3.2    Growth opportunities in emerging markets     61

5.2.4        CHALLENGES    62

5.2.4.1    Dearth of skilled orthopedic surgeons               62

5.3           VALUE CHAIN ANALYSIS               62

5.3.1        RESEARCH & PRODUCT DEVELOPMENT               63

5.3.2        RAW MATERIAL PROCUREMENT AND MANUFACTURING          64

5.3.3        DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES             64

5.4           SUPPLY CHAIN ANALYSIS             64

5.4.1        MANUFACTURERS           64

5.4.1.1    Prominent companies          64

5.4.1.2    Small and medium-sized enterprises 64

5.4.2        END USERS         65

5.5           ECOSYSTEM ANALYSIS  66

5.6           REGULATORY ANALYSIS               67

5.6.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             67

5.6.2        REGULATORY FRAMEWORK       70

5.6.2.1    North America      70

5.6.2.1.1 US           70

5.6.2.1.2 Canada   72

5.6.2.2    Europe   74

5.6.2.3    Asia Pacific            76

5.6.2.3.1 Japan      76

5.6.2.3.2 China      77

5.6.2.3.3 India       78

5.6.2.4    Latin America       79

5.6.2.4.1 Brazil      79

5.6.3        REGULATORY APPROVALS          79

5.7           REIMBURSEMENT SCENARIO     80

5.8           INVESTMENT AND FUNDING SCENARIO               82

5.9           PRICING ANALYSIS          83

5.9.1        AVERAGE SELLING PRICE, BY KEY PLAYER           84

5.9.2        AVERAGE SELLING PRICE TREND, BY REGION   85

5.10         TRADE ANALYSIS             87

5.10.1      IMPORT DATA  87

5.10.2      EXPORT DATA  88

5.11         PATENT ANALYSIS          88

5.12         PORTER’S FIVE FORCES ANALYSIS           91

5.12.1      THREAT OF NEW ENTRANTS      92

5.12.2      THREAT OF SUBSTITUTES          92

5.12.3      BARGAINING POWER OF SUPPLIERS       92

5.12.4      BARGAINING POWER OF BUYERS             92

5.12.5      INTENSITY OF COMPETITIVE RIVALRY 92

5.13         KEY STAKEHOLDERS & BUYING CRITERIA            93

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS           93

5.13.2      BUYING CRITERIA           94

5.14         KEY CONFERENCES AND EVENTS, 2024–2025        95

5.15         CASE STUDY ANALYSIS 96

5.15.1      CASE STUDY 1: DIGITAL PLATFORM DESIGNED TO IMPROVE

PATIENT CARE PATHWAYS         96

5.15.2      CASE STUDY 2: PARTIAL KNEE ARTHROPLASTY PERFORMED WITH ROSA PARTIAL KNEE SYSTEM             97

5.15.3      CASE STUDY 3: ACCURATE DATA GENERATION WITH SHAPEGRABBER 3D         97

5.16         TECHNOLOGY ANALYSIS             97

5.16.1      KEY TECHNOLOGIES     97

5.16.1.1  3D printing/additive manufacturing 97

5.16.2      COMPLEMENTARY TECHNOLOGIES       98

5.16.2.1  Robotic orthopedic surgery 98

5.16.3      ADJACENT TECHNOLOGIES       98

5.16.3.1  Diagnostic imaging               98

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       99

5.18         UNMET NEEDS 100

5.19         IMPACT OF AI ON JOINT REPLACEMENT DEVICES MARKET               101

5.19.1      KEY USE CASES 102

6               JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT                 103

6.1           INTRODUCTION              104

6.2           KNEE REPLACEMENT DEVICES 106

6.2.1        TOTAL KNEE REPLACEMENT DEVICES 107

6.2.1.1    Ongoing innovation in knee implants to support market growth                 107

6.2.2        PARTIAL KNEE REPLACEMENT DEVICES               107

6.2.2.1    Quick recovery and shorter hospital stays to drive segmental growth    107

6.2.3        REVISION KNEE REPLACEMENT DEVICES             108

6.2.3.1    Rising incidence of obesity and ongoing technological advancements to fuel growth              108

6.3           HIP REPLACEMENT DEVICES     109

6.3.1        TOTAL HIP REPLACEMENT DEVICES     110

6.3.1.1    Increasing number of hip fractures and increasing success rates of hip arthroplasty to support market                110

6.3.2        PARTIAL HIP REPLACEMENT DEVICES  111

6.3.2.1    Increasing geriatric population and rising focus on minimally invasive surgeries to boost market     111

6.3.3        REVISION HIP REPLACEMENT DEVICES 112

6.3.3.1    Improved longevity and better patient outcomes to drive growth                 112

6.3.4        HIP RESURFACING DEVICES       113

6.3.4.1    Improved stability and faster recovery to boost segment                 113

6.4           SHOULDER REPLACEMENT DEVICES MARKET   114

6.4.1        TOTAL SHOULDER REPLACEMENT DEVICES      115

6.4.1.1    Increasing launch of new shoulder replacement devices to support market growth        115

6.4.2        PARTIAL SHOULDER REPLACEMENT DEVICES  115

6.4.2.1    Growing incidence of rotator cuff disorders to drive growth                 115

6.4.3        REVERSE SHOULDER REPLACEMENT DEVICES  116

6.4.3.1    Rising number of reverse shoulder arthroplasty procedures to boost market          116

6.5           ANKLE REPLACEMENT DEVICES               117

6.5.1        TOTAL ANKLE REPLACEMENT DEVICES               118

6.5.1.1    Growing number of ankle replacement procedures to fuel uptake                 118

6.5.2        ANKLE FUSION/FIXATION DEVICES        119

6.5.2.1    Cost-effectiveness and improved surgical outcomes to propel market    119

6.6           ELBOW REPLACEMENT DEVICES              120

6.6.1        INCREASING FREQUENCY OF ELBOW JOINT FRACTURES AND GROWTH IN ELDERLY POPULATION TO DRIVE MARKET 120

6.7           WRIST REPLACEMENT DEVICES                120

6.7.1        GROWING NUMBER OF WRIST REPLACEMENT PROCEDURES TO DRIVE MARKET GROWTH       120

6.8           OTHER JOINT REPLACEMENT DEVICES 121

6.9           BONE GRAFT SUBSTITUTES       122

6.9.1        COST-EFFECTIVE AND EASY AVAILABILITY OF BONE GRAFT SUBSTITUTES TO PROPEL MARKET         122

7               JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE     123

7.1           INTRODUCTION              124

7.2           TOTAL REPLACEMENT PROCEDURES    124

7.2.1        INCREASING NUMBER OF HIP AND KNEE REPLACEMENT SURGERIES TO DRIVE MARKET GROWTH                 124

7.3           PARTIAL REPLACEMENT PROCEDURES 125

7.3.1        INCREASING INCIDENCE OF BONE-RELATED DISORDERS AND QUICKER RECOVERY PERIODS TO BOOST DEMAND             125

7.4           REVISION REPLACEMENT PROCEDURES               126

7.4.1        DEVELOPMENT OF SPECIALIZED IMPLANTS TO FUEL DEMAND             126

8               JOINT REPLACEMENT DEVICES MARKET, BY TYPE                 128

8.1           INTRODUCTION              129

8.2           CEMENTED FIXATION   129

8.2.1        RISING NUMBER OF JOINT REPLACEMENT SURGERIES AND DECREASE IN REVISION PROCEDURES TO DRIVE MARKET                 129

8.3           CEMENTLESS FIXATION                130

8.3.1        IMPROVED STABILITY AND DURABILITY TO FUEL SEGMENT GROWTH       130

8.4           HYBRID FIXATION           131

8.4.1        IMPROVED BONE GROWTH AND RAPID RECOVERY TO DRIVE MARKET 131

8.5           REVERSE HYBRID FIXATION       132

8.5.1        RISING INCIDENCE OF OSTEOARTHRITIS AND INCREASING NUMBER OF HIP REPLACEMENT SURGERIES TO FUEL MARKET GROWTH               132

9               JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE       133

9.1           INTRODUCTION              134

9.2           TRADITIONAL SURGERY               134

9.2.1        COST-EFFECTIVENESS AND HIGHER FAMILIARITY TO PROPEL MARKET GROWTH         134

9.3           MINIMALLY INVASIVE SURGERY               135

9.3.1        REDUCED PAIN AND FASTER RECOVERY TO DRIVE DEMAND             135

9.4           COMPUTER-ASSISTED SURGERY               136

9.4.1        IMPROVED ACCURACY AND REAL-TIME GUIDANCE TO FUEL GROWTH 136

10            JOINT REPLACEMENT DEVICES MARKET, BY END USER                 138

10.1         INTRODUCTION              139

10.2         HOSPITALS & SURGICAL CENTERS          139

10.2.1      RISING NUMBER OF ORTHOPEDIC SURGERIES TO DRIVE MARKET 139

10.3         AMBULATORY CARE CENTERS & TRAUMA UNITS                 140

10.3.1      COST-EFFECTIVE TREATMENTS OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH                 140

10.4         ORTHOPEDIC CLINICS  141

10.4.1      RISING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT MARKET GROWTH     141

11            JOINT REPLACEMENT DEVICES MARKET, BY REGION                 143

11.1         INTRODUCTION              144

11.2         NORTH AMERICA             144

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 150

11.2.2      US           151

11.2.2.1  Growing focus on launching technologically advanced hybrid implants to drive market     151

11.2.3      CANADA               154

11.2.3.1  Rising incidence of degenerative bone diseases to support market growth    154

11.3         EUROPE               157

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      157

11.3.2      GERMANY           163

11.3.2.1  Increasing focus on commercialization of joint replacement devices to boost demand     163

11.3.3      FRANCE                165

11.3.3.1  Increasing cases of obesity and subsequent rise in osteoporosis to drive market          165

11.3.4      UK          168

11.3.4.1  Increasing awareness of orthopedic conditions to boost demand                 168

11.3.5      ITALY    171

11.3.5.1  Growing focus on preventive care for musculoskeletal injuries to drive market          171

11.3.6      SPAIN    174

11.3.6.1  Rising preference for MIS techniques to support market growth                 174

11.3.7      REST OF EUROPE             177

11.4         ASIA PACIFIC     180

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 180

11.4.2      JAPAN   187

11.4.2.1  Rapidly growing geriatric population to propel market  187

11.4.3      CHINA  190

11.4.3.1  Expanding target patient population to drive market     190

11.4.4      INDIA    193

11.4.4.1  Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth               193

11.4.5      AUSTRALIA         196

11.4.5.1  Favorable government initiatives for bone health awareness to fuel market             196

11.4.6      SOUTH KOREA  199

11.4.6.1  Favorable government support for healthcare access to support market growth       199

11.4.7      REST OF ASIA PACIFIC   202

11.5         LATIN AMERICA                205

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 205

11.5.2      BRAZIL 211

11.5.2.1  Expansion of global market players for advanced product commercialization to boost demand  211

11.5.3      MEXICO                213

11.5.3.1  Favorable investments for medical device manufacturers to support market growth        213

11.5.4      REST OF LATIN AMERICA             216

11.6         MIDDLE EAST & AFRICA                219

11.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 219

11.6.2      GCC COUNTRIES              225

11.6.2.1  Rising focus on in-house manufacturing of advanced orthopedic devices to support market growth      225

11.6.3      REST OF MIDDLE EAST & AFRICA             228

12            COMPETITIVE LANDSCAPE         232

12.1         OVERVIEW          232

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2024                 232

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET              233

12.3         REVENUE ANALYSIS, 2019–2023  235

12.4         MARKET SHARE ANALYSIS, 2023                 236

12.5         COMPANY VALUATION AND FINANCIAL METRICS                 237

12.6         BRAND/PRODUCT COMPARISON             239

12.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 240

12.7.1      STARS   240

12.7.2      EMERGING LEADERS     240

12.7.3      PERVASIVE PLAYERS      240

12.7.4      PARTICIPANTS 240

12.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         242

12.7.5.1  Company footprint               242

12.7.5.2  Region footprint   243

12.7.5.3  Type footprint       244

12.7.5.4  Surgery type footprint          245

12.7.5.5  Type footprint       246

12.7.5.6  Technique footprint             247

12.7.5.7  End-user footprint                248

12.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        249

12.8.1      PROGRESSIVE COMPANIES         249

12.8.2      RESPONSIVE COMPANIES            249

12.8.3      DYNAMIC COMPANIES  249

12.8.4      STARTING BLOCKS         249

12.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 251

12.8.5.1  Detailed list of key startups/SMEs    251

12.8.5.2  Competitive benchmarking of startups/SMEs 252

12.9         COMPETITIVE SCENARIO             256

12.9.1      PRODUCT LAUNCHES AND APPROVALS               256

12.9.2      DEALS  259

12.9.3      EXPANSIONS     260

13            COMPANY PROFILES      261

13.1         KEY PLAYERS     261

13.1.1      ZIMMER BIOMET             261

13.1.1.1  Business overview 261

13.1.1.2  Products offered   262

13.1.1.3  Recent developments           265

13.1.1.3.1                Product launches and approvals         265

13.1.1.3.2                Deals      266

13.1.1.4  MnM view              266

13.1.1.4.1                Key strengths        266

13.1.1.4.2                Strategic choices   266

13.1.1.4.3                Weaknesses and competitive threats 267

13.1.2      STRYKER              268

13.1.2.1  Business overview 268

13.1.2.2  Products offered   269

13.1.2.3  Recent developments           273

13.1.2.3.1                Product launches and approvals         273

13.1.2.3.2                Deals      273

13.1.2.3.3                Expansions             274

13.1.2.4  MnM view              274

13.1.2.4.1                Right to win           274

13.1.2.4.2                Strategic choices   274

13.1.2.4.3                Weaknesses and competitive threats 274

13.1.3      JOHNSON & JOHNSON MEDTECH             275

13.1.3.1  Business overview 275

13.1.3.2  Products offered   276

13.1.3.3  Recent developments           278

13.1.3.3.1                Product launches and approvals         278

13.1.3.3.2                Deals      279

13.1.3.4  MnM view              279

13.1.3.4.1                Right to win           279

13.1.3.4.2                Strategic choices   279

13.1.3.4.3                Weaknesses and competitive threats 279

13.1.4      SMITH+NEPHEW              280

13.1.4.1  Business overview 280

13.1.4.2  Products offered   282

13.1.4.3  Recent developments           283

13.1.4.3.1                Product launches and approvals         283

13.1.4.3.2                Deals      284

13.1.4.3.3                Expansions             285

13.1.4.4  MnM view              285

13.1.4.4.1                Key strengths        285

13.1.4.4.2                Strategic choices   285

13.1.4.4.3                Weaknesses and competitive threats 285

13.1.5      B. BRAUN             286

13.1.5.1  Business overview 286

13.1.5.2  Products offered   288

13.1.5.3  MnM view              289

13.1.5.3.1                Right to win           289

13.1.5.3.2                Strategic choices   289

13.1.5.3.3                Weaknesses and competitive threats 289

13.1.6      GLOBUS MEDICAL          290

13.1.6.1  Business overview 290

13.1.6.2  Products offered   292

13.1.6.3  Recent developments           293

13.1.6.3.1                Product launches and approvals         293

13.1.6.3.2                Deals      294

13.1.7      ARTHREX, INC. 295

13.1.7.1  Business overview 295

13.1.7.2  Products offered   295

13.1.8      ENOVIS 301

13.1.8.1  Business overview 301

13.1.8.2  Products offered   302

13.1.8.3  Recent developments           304

13.1.8.3.1                Product launches and approvals         304

13.1.8.3.2                Deals      305

13.1.8.3.3                Expansions             306

13.1.9      ACUMED LLC     307

13.1.9.1  Business overview 307

13.1.9.2  Products offered   307

13.1.9.3  Recent developments           309

13.1.9.3.1                Product launches and approvals         309

13.1.9.3.2                Deals      310

13.1.9.3.3                Expansions             310

13.1.10   ORTHOFIX MEDICAL INC.            311

13.1.10.1                 Business overview 311

13.1.10.2                 Products offered   312

13.1.10.3                 Recent developments           314

13.1.10.3.1             Product launches and approvals         314

13.1.10.3.2             Deals      315

13.1.11   MICROPORT SCIENTIFIC CORPORATION             316

13.1.11.1                 Business overview 316

13.1.11.2                 Products offered   318

13.1.11.3                 Recent developments           319

13.1.11.3.1             Product launches and approvals         319

13.1.11.3.2             Deals      319

13.1.12   CONMED CORPORATION             320

13.1.12.1                 Business overview 320

13.1.12.2                 Products offered   321

13.1.12.3                 Recent developments           323

13.1.12.3.1             Deals      323

13.1.13   MEDACTA INTERNATIONAL       324

13.1.13.1                 Business overview 324

13.1.13.2                 Products offered   326

13.1.13.3                 Recent developments           327

13.1.13.3.1             Product launches and approvals         327

13.1.13.3.2             Deals      327

13.1.13.3.3             Expansions             327

13.1.14   PARAGON 28, INC.           328

13.1.14.1                 Business overview 328

13.1.14.2                 Products offered   329

13.1.14.3                 Recent developments           331

13.1.14.3.1             Product launches and approvals         331

13.1.14.3.2             Deals      332

13.1.15   MERIL LIFE SCIENCES PVT. LTD.               333

13.1.15.1                 Business overview 333

13.1.15.2                 Products offered   333

13.1.15.3                 Recent developments           335

13.1.15.3.1             Expansions             335

13.1.16   GPC MEDICAL LTD.        336

13.1.16.1                 Business overview 336

13.1.16.2                 Products offered   336

13.1.17   MAXX ORTHOPEDICS, INC.          337

13.1.17.1                 Business overview 337

13.1.17.2                 Products offered   337

13.1.17.3                 Recent developments           338

13.1.17.3.1             Product launches and approvals         338

13.1.17.3.2             Deals      338

13.1.18   AUXEIN 339

13.1.18.1                 Business overview 339

13.1.18.2                 Products offered   339

13.1.18.3                 Recent developments           339

13.1.18.3.1             Deals      339

13.1.19   NORAKER            340

13.1.19.1                 Business overview 340

13.1.19.2                 Products offered   340

13.1.19.3                 Recent developments           340

13.1.19.3.1             Product launches and approvals         340

13.1.19.3.2             Deals      341

13.1.20   NEXTSTEP ARTHROPEDIX           342

13.1.20.1                 Business overview 342

13.1.20.2                 Products offered   342

13.1.21   EXACTECH, INC.               343

13.1.21.1                 Business overview 343

13.1.21.2                 Products offered   343

13.1.21.3                 Recent developments           344

13.1.21.3.1             Product launches and approvals         344

13.1.21.3.2             Deals      345

13.2         OTHER PLAYERS              346

13.2.1      FH ORTHO          346

13.2.2      SYMBIOS ORTHOPÉDIE S.A.        347

13.2.3      MADISON ORTHO            348

13.2.4      GREEN SURGICALS PVT. LTD.    350

13.2.5      SIORA SURGICAL PVT. LTD.        355

13.2.6      ORTHOPEDIATRICS CORP.          359

13.2.7      RESTOR3D          360

13.2.8      DOUBLE MEDICAL TECHNOLOGY INC. 361

13.2.9      TREACE MEDICAL CONCEPTS, INC.         365

13.2.10   AK MEDICAL      366

14            APPENDIX           368

14.1         DISCUSSION GUIDE        368

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                372

14.3         CUSTOMIZATION OPTIONS        374

14.4         RELATED REPORTS         374

14.5         AUTHOR DETAILS           375

LIST OF TABLES

TABLE 1                JOINT REPLACEMENT DEVICES MARKET: INCLUSIONS & EXCLUSIONS       32

TABLE 2                JOINT REPLACEMENT DEVICES MARKET: PARAMETRIC ASSUMPTIONS     44

TABLE 3                JOINT REPLACEMENT DEVICES MARKET: RISK ASSESSMENT     45

TABLE 4                JOINT REPLACEMENT DEVICES MARKET: GRANTS AND FUNDING                59

TABLE 5                DIFFERENCES IN INFLATION-ADJUSTED MEDICARE REIMBURSEMENT    60

TABLE 6                JOINT REPLACEMENT DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 67

TABLE 7                NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 67

TABLE 8                EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  68

TABLE 9                ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  68

TABLE 10              LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 11              MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             69

TABLE 12              US FDA: MEDICAL DEVICE CLASSIFICATION                 70

TABLE 13              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              70

TABLE 14              US: CLASSIFICATION OF JOINT REPLACEMENT DEVICES              71

TABLE 15              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      72

TABLE 16              JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL

AND MEDICAL DEVICE AGENCY (PMDA)              76

TABLE 17              CHINA: CLASSIFICATION OF MEDICAL DEVICES                 77

TABLE 18              REGULATORY APPROVALS FOR JOINT REPLACEMENT DEVICES, BY COUNTRY 79

TABLE 19              US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (DRG CODES)                 80

TABLE 20              US: MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC IMPLANTATION SERVICES, 2023 (CPT CODES)                 81

TABLE 21              CANADA: MPS BILLING CODES, 2023       81

TABLE 22              GERMANY: OPS CODES, 2023       82

TABLE 23              UK: OPCS CODES, 2023   82

TABLE 24              AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,

BY KEY PLAYER, 2023 (USD)         85

TABLE 25              AVERAGE SELLING PRICE TREND OF JOINT REPLACEMENT DEVICES,

BY REGION, 2021–2023 (USD)      86

TABLE 26             IMPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)      87

TABLE 27             EXPORT DATA FOR HS CODE 9021, BY COUNTRY, 2019–2023 (USD THOUSAND)      88

TABLE 28              LIST OF MAJOR PATENT INNOVATIONS AND REGISTRATIONS,

JANUARY 2014–SEPTEMBER 2024                90

TABLE 29              JOINT REPLACEMENT DEVICES MARKET: PORTER’S FIVE FORCES 91

TABLE 30              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS            93

TABLE 31              KEY BUYING CRITERIA, BY END USER    94

TABLE 32              JOINT REPLACEMENT DEVICES MARKET: KEY CONFERENCES

AND EVENTS, 2024–2025                 95

TABLE 33              JOINT REPLACEMENT DEVICES MARKET: CURRENT UNMET NEEDS            100

TABLE 34              JOINT REPLACEMENT DEVICES MARKET: INTENSITY OF CURRENT UNMET NEEDS              100

TABLE 35              JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            104

TABLE 36              JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          105

TABLE 37              JOINT REPLACEMENT PROCEDURES DATA, (2023 VS 2030)     105

TABLE 38              KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                106

TABLE 39              KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          106

TABLE 40              TOTAL KNEE REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            107

TABLE 41              PARTIAL KNEE REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            108

TABLE 42              REVISION KNEE REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            108

TABLE 43              HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)            109

TABLE 44              HIP REPLACEMENT DEVICES, BY REGION, 2022–2030 (USD MILLION)       110

TABLE 45              TOTAL HIP REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            111

TABLE 46              PARTIAL HIP REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            112

TABLE 47              REVISION HIP REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            112

TABLE 48              HIP RESURFACING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          113

TABLE 49              SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            114

TABLE 50              SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            114

TABLE 51              TOTAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            115

TABLE 52              PARTIAL SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            116

TABLE 53              REVERSE SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            117

TABLE 54              ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                117

TABLE 55              ANKLE REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          118

TABLE 56              TOTAL ANKLE REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            119

TABLE 57              ANKLE FUSION/FIXATION DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            119

TABLE 58              ELBOW REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          120

TABLE 59              WRIST REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          121

TABLE 60              OTHER JOINT REPLACEMENT DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            121

TABLE 61              BONE GRAFT SUBSTITUTES MARKET, BY REGION, 2022–2030 (USD MILLION)          122

TABLE 62              JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,

2022–2030 (USD MILLION)            124

TABLE 63              JOINT REPLACEMENT DEVICES MARKET FOR TOTAL REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 125

TABLE 64              JOINT REPLACEMENT DEVICES MARKET FOR PARTIAL REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 126

TABLE 65              JOINT REPLACEMENT DEVICES MARKET FOR REVISION REPLACEMENT PROCEDURES, BY REGION, 2022–2030 (USD MILLION) 127

TABLE 66              JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                129

TABLE 67              JOINT REPLACEMENT DEVICES MARKET FOR CEMENTED FIXATION, BY REGION, 2022–2030 (USD MILLION)                 130

TABLE 68              JOINT REPLACEMENT DEVICES MARKET FOR CEMENTLESS FIXATION,

BY REGION, 2022–2030 (USD MILLION)   131

TABLE 69              JOINT REPLACEMENT DEVICES MARKET FOR HYBRID FIXATION, BY REGION, 2022–2030 (USD MILLION)                 132

TABLE 70              JOINT REPLACEMENT DEVICES MARKET FOR REVERSE HYBRID FIXATION,

BY REGION, 2022–2030 (USD MILLION)   132

TABLE 71              JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)            134

TABLE 72              JOINT REPLACEMENT DEVICES MARKET FOR TRADITIONAL SURGERY,

BY REGION, 2022–2030 (USD MILLION)   135

TABLE 73              JOINT REPLACEMENT DEVICES MARKET FOR MINIMALLY INVASIVE SURGERY,

BY REGION, 2022–2030 (USD MILLION)   136

TABLE 74              JOINT REPLACEMENT DEVICES MARKET FOR COMPUTER-ASSISTED SURGERY,

BY REGION, 2022–2030 (USD MILLION)   137

TABLE 75              JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2022–2030 (USD MILLION)            139

TABLE 76              JOINT REPLACEMENT DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2022–2030 (USD MILLION)            140

TABLE 77              JOINT REPLACEMENT DEVICES MARKET FOR AMBULATORY CARE CENTERS & TRAUMA UNITS, BY REGION, 2022–2030 (USD MILLION)            141

TABLE 78              JOINT REPLACEMENT DEVICES MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2022–2030 (USD MILLION)                 142

TABLE 79              JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          144

TABLE 80              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            146

TABLE 81              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            146

TABLE 82              NORTH AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            147

TABLE 83              NORTH AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            147

TABLE 84              NORTH AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            148

TABLE 85              NORTH AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            148

TABLE 86              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION)                 149

TABLE 87              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            149

TABLE 88              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)            150

TABLE 89              NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2022–2030 (USD MILLION)            150

TABLE 90              NORTH AMERICA: KEY MACROINDICATORS                 151

TABLE 91              US: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            152

TABLE 92              US: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                152

TABLE 93              US: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                153

TABLE 94              US: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            153

TABLE 95              US: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            154

TABLE 96              CANADA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            155

TABLE 97              CANADA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            155

TABLE 98             CANADA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            156

TABLE 99              CANADA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            156

TABLE 100            CANADA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            157

TABLE 101            EUROPE: KEY MACROINDICATORS          158

TABLE 102            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            158

TABLE 103            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            159

TABLE 104            EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            159

TABLE 105            EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            160

TABLE 106            EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            160

TABLE 107            EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            161

TABLE 108            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,

2022–2030 (USD MILLION)            161

TABLE 109            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            162

TABLE 110            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)            162

TABLE 111            EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2022–2030 (USD MILLION)            162

TABLE 112            GERMANY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            163

TABLE 113            GERMANY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            164

TABLE 114            GERMANY: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            164

TABLE 115            GERMANY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            165

TABLE 116            GERMANY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            165

TABLE 117            FRANCE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)          166

TABLE 118            FRANCE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            167

TABLE 119            FRANCE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            167

TABLE 120            FRANCE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            168

TABLE 121            FRANCE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            168

TABLE 122            UK: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            169

TABLE 123            UK: KNEE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                169

TABLE 124            UK: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)                170

TABLE 125            UK: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            170

TABLE 126            UK: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            171

TABLE 127          ITALY: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            172

TABLE 128            ITALY: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            172

TABLE 129            ITALY: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)         173

TABLE 130            ITALY: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            173

TABLE 131            ITALY: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            174

TABLE 132          SPAIN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            175

TABLE 133            SPAIN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            175

TABLE 134            SPAIN: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            176

TABLE 135            SPAIN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            176

TABLE 136            SPAIN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            177

TABLE 137            REST OF EUROPE: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            178

TABLE 138            REST OF EUROPE: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            178

TABLE 139            REST OF EUROPE: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            179

TABLE 140            REST OF EUROPE: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            179

TABLE 141            REST OF EUROPE: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            180

TABLE 142            ASIA PACIFIC: KEY MACROINDICATORS                 181

TABLE 143            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            183

TABLE 144            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            183

TABLE 145            ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            184

TABLE 146            ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2

022–2030 (USD MILLION)               184

TABLE 147            ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            185

TABLE 148            ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            185

TABLE 149            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,

2022–2030 (USD MILLION)            186

TABLE 150            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            186

TABLE 151            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)            187

TABLE 152            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2022–2030 (USD MILLION)            187

TABLE 153          JAPAN: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            188

TABLE 154            JAPAN: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            188

TABLE 155            JAPAN: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            189

TABLE 156            JAPAN: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            189

TABLE 157            JAPAN: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            190

TABLE 158            CHINA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            191

TABLE 159          CHINA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            191

TABLE 160            CHINA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            192

TABLE 161            CHINA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            192

TABLE 162            CHINA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            193

TABLE 163            INDIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            194

TABLE 164            INDIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            194

TABLE 165            INDIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)         195

TABLE 166            INDIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            195

TABLE 167            INDIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            196

TABLE 168            AUSTRALIA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            197

TABLE 169            AUSTRALIA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            197

TABLE 170            AUSTRALIA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            198

TABLE 171            AUSTRALIA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            198

TABLE 172            AUSTRALIA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            199

TABLE 173            SOUTH KOREA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            200

TABLE 174            SOUTH KOREA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            200

TABLE 175            SOUTH KOREA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            201

TABLE 176            SOUTH KOREA: SHOULDER REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         201

TABLE 177            SOUTH KOREA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            202

TABLE 178            REST OF ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               203

TABLE 179            REST OF ASIA PACIFIC: KNEE REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         203

TABLE 180            REST OF ASIA PACIFIC: HIP REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         204

TABLE 181            REST OF ASIA PACIFIC: SHOULDER REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         204

TABLE 182            REST OF ASIA PACIFIC: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            205

TABLE 183            LATIN AMERICA: KEY MACROINDICATORS                 206

TABLE 184            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            206

TABLE 185            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            207

TABLE 186            LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            207

TABLE 187            LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            208

TABLE 188            LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            208

TABLE 189            LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            209

TABLE 190            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION)                 209

TABLE 191            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            210

TABLE 192            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2022–2030 (USD MILLION)            210

TABLE 193            LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2022–2030 (USD MILLION)            210

TABLE 194            BRAZIL: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            211

TABLE 195            BRAZIL: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            212

TABLE 196            BRAZIL: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            212

TABLE 197            BRAZIL: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            213

TABLE 198            BRAZIL: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            213

TABLE 199            MEXICO: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            214

TABLE 200            MEXICO: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            214

TABLE 201            MEXICO: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            215

TABLE 202            MEXICO: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            215

TABLE 203            MEXICO: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            216

TABLE 204            REST OF LATIN AMERICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 217

TABLE 205            REST OF LATIN AMERICA: KNEE REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         217

TABLE 206            REST OF LATIN AMERICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            218

TABLE 207            REST OF LATIN AMERICA: SHOULDER REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         218

TABLE 208            REST OF LATIN AMERICA: ANKLE REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         219

TABLE 209            MIDDLE EAST & AFRICA: KEY MACROINDICATORS      220

TABLE 210            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)                 220

TABLE 211            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION)                 221

TABLE 212            MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            221

TABLE 213            MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            222

TABLE 214            MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)            222

TABLE 215            MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)  223

TABLE 216            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE, 2022–2030 (USD MILLION)                 223

TABLE 217            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            224

TABLE 218            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE, 2022–2030 (USD MILLION)                 224

TABLE 219            MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET,

BY END USER, 2022–2030 (USD MILLION)               225

TABLE 220            GCC COUNTRIES: JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2022–2030 (USD MILLION)            226

TABLE 221            GCC COUNTRIES: KNEE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)          226

TABLE 222            GCC COUNTRIES: HIP REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)          227

TABLE 223            GCC COUNTRIES: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            227

TABLE 224            GCC COUNTRIES: ANKLE REPLACEMENT DEVICES MARKET, BY TYPE,

2022–2030 (USD MILLION)            228

TABLE 225            REST OF MIDDLE EAST & AFRICA: JOINT REPLACEMENT DEVICES MARKET,

BY PRODUCT, 2022–2030 (USD MILLION)               229

TABLE 226            REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         229

TABLE 227            REST OF MIDDLE EAST & AFRICA: HIP REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         230

TABLE 228            REST OF MIDDLE EAST & AFRICA: SHOULDER REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION)            230

TABLE 229            REST OF MIDDLE EAST & AFRICA: ANKLE REPLACEMENT DEVICES MARKET,

BY TYPE, 2022–2030 (USD MILLION)         231

TABLE 230            OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2021−2024            233

TABLE 231            JOINT REPLACEMENT DEVICES MARKET: DEGREE OF COMPETITION         236

TABLE 232            JOINT REPLACEMENT DEVICES MARKET: REGION FOOTPRINT     243

TABLE 233            JOINT REPLACEMENT DEVICES MARKET: PRODUCT TYPE FOOTPRINT     244

TABLE 234            JOINT REPLACEMENT DEVICES MARKET: SURGERY TYPE FOOTPRINT       245

TABLE 235            JOINT REPLACEMENT DEVICES MARKET: TYPE FOOTPRINT       246

TABLE 236            JOINT REPLACEMENT DEVICES MARKET: TECHNIQUE FOOTPRINT             247

TABLE 237            JOINT REPLACEMENT DEVICES MARKET: END-USER FOOTPRINT            248

TABLE 238            JOINT REPLACEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SMES                251

TABLE 239            JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES (1/4) 252

TABLE 240            JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING O

F KEY STARTUPS/SMES (2/4)       253

TABLE 241            JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES (3/4)   254

TABLE 242            JOINT REPLACEMENT DEVICES MARKET: COMPETITIVE BENCHMARKING

OF KEY STARTUPS/SMES (4/4)   255

TABLE 243            JOINT REPLACEMENT DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–DECEMBER 2024                256

TABLE 244            JOINT REPLACEMENT DEVICES MARKET: DEALS,

JANUARY 2021–DECEMBER 2024 259

TABLE 245            JOINT REPLACEMENT DEVICES MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024    260

TABLE 246            ZIMMER BIOMET: COMPANY OVERVIEW                 261

TABLE 247            ZIMMER BIOMET: PRODUCTS OFFERED                 262

TABLE 248            ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024    265

TABLE 249            ZIMMER BIOMET: DEALS, JANUARY 2021−DECEMBER 2024   266

TABLE 250            STRYKER: COMPANY OVERVIEW               268

TABLE 251            STRYKER: PRODUCTS OFFERED                269

TABLE 252            STRYKER: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021−DECEMBER 2024               273

TABLE 253            STRYKER: DEALS, JANUARY 2021− DECEMBER 2024        273

TABLE 254            STRYKER: EXPANSIONS, JANUARY 2021− DECEMBER 2024                274

TABLE 255            JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW          275

TABLE 256            JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED             276

TABLE 257            JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024                 278

TABLE 258            JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021−DECEMBER 2024               279

TABLE 259            SMITH+NEPHEW: COMPANY OVERVIEW                 280

TABLE 260            SMITH+NEPHEW: PRODUCTS OFFERED                 282

TABLE 261            SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021− DECEMBER 2024              283

TABLE 262            SMITH+NEPHEW: DEALS, JANUARY 2021−DECEMBER 2024   284

TABLE 263            SMITH+NEPHEW: EXPANSIONS, JANUARY 2021−DECEMBER 2024   285

TABLE 264            B. BRAUN: COMPANY OVERVIEW              286

TABLE 265            B. BRAUN: PRODUCTS OFFERED               288

TABLE 266            GLOBUS MEDICAL: COMPANY OVERVIEW                 290

TABLE 267            GLOBUS MEDICAL: PRODUCTS OFFERED                 292

TABLE 268            GLOBUS MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−DECEMBER 2024    293

TABLE 269            GLOBUS MEDICAL: DEALS, JANUARY 2021−DECEMBER 2024   294

TABLE 270            ARTHREX, INC.: COMPANY OVERVIEW  295

TABLE 271            ARTHREX, INC.: PRODUCTS OFFERED   295

TABLE 272            ENOVIS: COMPANY OVERVIEW 301

TABLE 273            ENOVIS: PRODUCTS OFFERED  302

TABLE 274            ENOVIS: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021−DECEMBER 2024               304

TABLE 275            ENOVIS: DEALS, JANUARY 2021−DECEMBER 2024        305

TABLE 276            ENOVIS: EXPANSIONS, JANUARY 2021−DECEMBER 2024   306

TABLE 277            ACUMED LLC: COMPANY OVERVIEW     307

TABLE 278            ACUMED LLC: PRODUCTS OFFERED      307

TABLE 279            ACUMED LLC: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021−DECEMBER 2024               309

TABLE 280            ACUMED: DEALS, JANUARY 2021− DECEMBER 2024        310

TABLE 281            ACUMED: EXPANSIONS, JANUARY 2021−DECEMBER 2024   310

TABLE 282            ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW          311

TABLE 283            ORTHOFIX MEDICAL INC.: PRODUCTS OFFERED             312

TABLE 284            ORTHOFIX MEDICAL INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021− DECEMBER 2024              314

TABLE 285            ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2021−DECEMBER 2024   315

TABLE 286            MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW   316

TABLE 287            MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED    318

TABLE 288            MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024                319

TABLE 289            MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024                319

TABLE 290            CONMED CORPORATION: COMPANY OVERVIEW          320

TABLE 291            CONMED CORPORATION: PRODUCTS OFFERED             321

TABLE 292            CONMED CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024   323

TABLE 293            MEDACTA INTERNATIONAL: COMPANY OVERVIEW          324

TABLE 294            MEDACTA INTERNATIONAL: PRODUCTS OFFERED             326

TABLE 295            MEDACTA INTERNATIONAL: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021− DECEMBER 2024            327

TABLE 296            MEDACTA INTERNATIONAL: DEALS, JANUARY 2021−DECEMBER 2024   327

TABLE 297            MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021−DECEMBER 2024               327

TABLE 298            PARAGON 28, INC.: COMPANY OVERVIEW                 328

TABLE 299            PARAGON 28, INC.: PRODUCTS OFFERED                 329

TABLE 300            PARAGON 28, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024   331

TABLE 301            PARAGON 28, INC.: DEALS, JANUARY 2021− DECEMBER 2024                332

TABLE 302            MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW          333

TABLE 303            MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED             333

TABLE 304            MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2021− DECEMBER 2024              335

TABLE 305            GPC MEDICAL LTD.: COMPANY OVERVIEW                 336

TABLE 306            GPC MEDICAL LTD.: PRODUCTS OFFERED                 336

TABLE 307            MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW          337

TABLE 308            MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED             337

TABLE 309            MAXX ORTHOPEDICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− DECEMBER 2024                 338

TABLE 310            MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2021−DECEMBER 2024   338

TABLE 311            AUXEIN: COMPANY OVERVIEW 339

TABLE 312            AUXEIN: PRODUCTS OFFERED  339

TABLE 313            AUXEIN: DEALS, JANUARY 2021−DECEMBER 2024        339

TABLE 314            NORAKER: COMPANY OVERVIEW             340

TABLE 315            NORAKER: PRODUCTS OFFERED              340

TABLE 316            NORAKER: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021−DECEMBER 2024               340

TABLE 317            NORAKER: DEALS, JANUARY 2021−DECEMBER 2024        341

TABLE 318            NEXTSTEP ARTHROPEDIX: COMPANY OVERVIEW          342

TABLE 319            NEXTSTEP ARTHROPEDIX: PRODUCTS OFFERED             342

TABLE 320            EXACTECH, INC.: COMPANY OVERVIEW                 343

TABLE 321            EXACTECH, INC.: PRODUCTS OFFERED 343

TABLE 322            EXACTECH, INC.: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2021− DECEMBER 2024              344

TABLE 323            EXACTECH, INC.: DEALS, JANUARY 2021−DECEMBER 2024   345

TABLE 324            FH ORTHO: COMPANY OVERVIEW           346

TABLE 325            SYMBIOS ORTHOPÉDIE S.A.: COMPANY OVERVIEW          347

TABLE 326            MADISON ORTHO: COMPANY OVERVIEW                 348

TABLE 327            GREEN SURGICALS PVT. LTD.: COMPANY OVERVIEW          350

TABLE 328            SIORA SURGICAL PVT. LTD.: COMPANY OVERVIEW          355

TABLE 329            ORTHOPEDIATRICS CORP.: COMPANY OVERVIEW          359

TABLE 330            RESTOR3D: COMPANY OVERVIEW           360

TABLE 331            DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW   361

TABLE 332            TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW          365

TABLE 333            AK MEDICAL: COMPANY OVERVIEW       366

LIST OF FIGURES

FIGURE 1              JOINT REPLACEMENT DEVICES MARKET SEGMENTATION

AND GEOGRAPHICAL SPREAD  31

FIGURE 2              JOINT REPLACEMENT DEVICES MARKET: YEARS CONSIDERED    33

FIGURE 3              JOINT REPLACEMENT DEVICES MARKET: RESEARCH DESIGN         34

FIGURE 4              JOINT REPLACEMENT DEVICES MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)                36

FIGURE 5              JOINT REPLACEMENT DEVICES: KEY INSIGHTS FROM PRIMARIES             37

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS     37

FIGURE 7              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     38

FIGURE 8              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           39

FIGURE 9              JOINT REPLACEMENT DEVICES MARKET: COMPANY REVENUE ESTIMATION          40

FIGURE 10            JOINT REPLACEMENT DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 41

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 42

FIGURE 12            JOINT REPLACEMENT DEVICES MARKET: DATA TRIANGULATION             43

FIGURE 13            JOINT REPLACEMENT DEVICES MARKET, BY PRODUCT,

2024 VS. 2030 (USD MILLION)      46

FIGURE 14            JOINT REPLACEMENT DEVICES MARKET, BY SURGERY TYPE,

2024 VS. 2030 (USD MILLION)      47

FIGURE 15            JOINT REPLACEMENT DEVICES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION)         47

FIGURE 16            JOINT REPLACEMENT DEVICES MARKET, BY TECHNIQUE,

2024 VS. 2030 (USD MILLION)      48

FIGURE 17            JOINT REPLACEMENT DEVICES MARKET, BY END USER,

2024 VS. 2030 (USD MILLION)      49

FIGURE 18            GEOGRAPHIC SNAPSHOT OF JOINT REPLACEMENT DEVICES MARKET           50

FIGURE 19            INCREASING GERIATRIC POPULATION AND RISING RESEARCH

FUNDING TO DRIVE MARKET    51

FIGURE 20            HIP REPLACEMENT DEVICES TO COMMAND LARGEST

MARKET SHARE DURING STUDY PERIOD             52

FIGURE 21            TOTAL REPLACEMENT PROCEDURES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD                53

FIGURE 22            HOSPITALS & SURGICAL CENTERS TO COMMAND LARGEST MARKET SHARE FROM 2024 TO 2030                 54

FIGURE 23            CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD         55

FIGURE 24            JOINT REPLACEMENT DEVICES MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     56

FIGURE 25            JOINT REPLACEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS               63

FIGURE 26            JOINT REPLACEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS             65

FIGURE 27            JOINT REPLACEMENT DEVICES MARKET: ECOSYSTEM ANALYSIS  66

FIGURE 28            PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES      71

FIGURE 29            CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES                73

FIGURE 30            EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES              75

FIGURE 31            INVESTMENT AND FUNDING SCENARIO, 2019−2023            82

FIGURE 32            NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019−2023            83

FIGURE 33            VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)            83

FIGURE 34            AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,

BY PRODUCT, 2023 (USD)             84

FIGURE 35            AVERAGE SELLING PRICE OF JOINT REPLACEMENT DEVICES,

BY REGION, 2023 (USD) 85

FIGURE 36            PATENT ANALYSIS FOR JOINT REPLACEMENT DEVICES MARKET (JANUARY 2014–SEPTEMBER 2024)      89

FIGURE 37            JOINT REPLACEMENT DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS           91

FIGURE 38            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF J

OINT REPLACEMENT DEVICES 93

FIGURE 39            KEY BUYING CRITERIA, BY END USER    94

FIGURE 40            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           99

FIGURE 41            MARKET POTENTIAL OF AI IN JOINT REPLACEMENT DEVICES MARKET           101

FIGURE 42            NORTH AMERICA: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT    145

FIGURE 43            ASIA PACIFIC: JOINT REPLACEMENT DEVICES MARKET SNAPSHOT       182

FIGURE 44            REVENUE SHARE ANALYSIS OF KEY PLAYERS IN JOINT REPLACEMENT DEVICES MARKET, 2019−2023       235

FIGURE 45            JOINT REPLACEMENT DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023               236

FIGURE 46            EV/EBITDA OF KEY VENDORS, 2024         237

FIGURE 47            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024            238

FIGURE 48            JOINT REPLACEMENT DEVICES MARKET: BRAND/PRODUCT COMPARISON             239

FIGURE 49            JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023  241

FIGURE 50            JOINT REPLACEMENT DEVICES MARKET: COMPANY FOOTPRINT 242

FIGURE 51            JOINT REPLACEMENT DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 250

FIGURE 52            ZIMMER BIOMET: COMPANY SNAPSHOT (2023)                 262

FIGURE 53            STRYKER: COMPANY SNAPSHOT (2023) 269

FIGURE 54            JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023)             276

FIGURE 55            SMITH+NEPHEW: COMPANY SNAPSHOT (2023)                 281

FIGURE 56            B. BRAUN: COMPANY SNAPSHOT (2023)                 287

FIGURE 57            GLOBUS MEDICAL: COMPANY SNAPSHOT (2023)    291

FIGURE 58            ENOVIS: COMPANY SNAPSHOT (2023)    302

FIGURE 59            ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2023)             312

FIGURE 60            MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)      317

FIGURE 61            CONMED CORPORATION: COMPANY SNAPSHOT (2023)             321

FIGURE 62            MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023)             325

FIGURE 63            PARAGON 28, INC.: COMPANY SNAPSHOT (2023)                 329

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 尿失禁デバイス市場 – 2030年までの世界予測 2025-03-12
• 医療用加湿器市場 – 2029年までの世界予測 2025-03-11
• BOPETフィルム市場 – 2029年までの世界予測 2025-03-11
• 金ナノ粒子市場 – 2029年までの世界予測 2025-03-07
• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07

MarketsandMarkets  出版レポート一覧